Literature DB >> 17037556

SARS-CoV, but not HCoV-NL63, utilizes cathepsins to infect cells: viral entry.

I-Chueh Huang1, Berend Jan Bosch, Wenhui Li, Michael Farzan, Peter M Rottier, Hyeryun Choe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17037556      PMCID： PMC7123842          DOI： 10.1007/978-0-387-33012-9_60

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  14 in total

1.  Sites and determinants of early cleavages in the proteolytic processing pathway of reovirus surface protein sigma3.

Authors:  Judit Jané-Valbuena; Laura A Breun; Leslie A Schiff; Max L Nibert
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry.

Authors:  Graham Simmons; Jacqueline D Reeves; Andrew J Rennekamp; Sean M Amberg; Andrew J Piefer; Paul Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-09       Impact factor: 11.205

3.  Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection.

Authors:  Kartik Chandran; Nancy J Sullivan; Ute Felbor; Sean P Whelan; James M Cunningham
Journal:  Science       Date:  2005-04-14       Impact factor: 47.728

4.  Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells.

Authors:  Daniel H Ebert; Jan Deussing; Christoph Peters; Terence S Dermody
Journal:  J Biol Chem       Date:  2002-05-01       Impact factor: 5.157

5.  Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry.

Authors:  Heike Hofmann; Krzysztof Pyrc; Lia van der Hoek; Martina Geier; Ben Berkhout; Stefan Pöhlmann
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-16       Impact factor: 11.205

6.  Addition of exogenous protease facilitates reovirus infection in many restrictive cells.

Authors:  Joseph W Golden; Jessica Linke; Stephen Schmechel; Kara Thoemke; Leslie A Schiff
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

7.  Feline aminopeptidase N is a receptor for all group I coronaviruses.

Authors:  D B Tresnan; K V Holmes
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

8.  Mutant cells selected during persistent reovirus infection do not express mature cathepsin L and do not support reovirus disassembly.

Authors:  G S Baer; D H Ebert; C J Chung; A H Erickson; T S Dermody
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

9.  Expression cloning of functional receptor used by SARS coronavirus.

Authors:  Peigang Wang; Jian Chen; Aihua Zheng; Yuchun Nie; Xuanling Shi; Wei Wang; Guangwen Wang; Min Luo; Huijun Liu; Lei Tan; Xijun Song; Zai Wang; Xiaolei Yin; Xiuxia Qu; Xiaojing Wang; Tingting Qing; Mingxiao Ding; Hongkui Deng
Journal:  Biochem Biophys Res Commun       Date:  2004-03-05       Impact factor: 3.575

10.  Human aminopeptidase N is a receptor for human coronavirus 229E.

Authors:  C L Yeager; R A Ashmun; R K Williams; C B Cardellichio; L H Shapiro; A T Look; K V Holmes
Journal:  Nature       Date:  1992-06-04       Impact factor: 49.962
View more
  15 in total

1.  Role of proteases in the release of porcine epidemic diarrhea virus from infected cells.

Authors:  Kazuya Shirato; Shutoku Matsuyama; Makoto Ujike; Fumihiro Taguchi
Journal:  J Virol       Date:  2011-05-25       Impact factor: 5.103

2.  Inhibition of endoplasmic reticulum-resident glucosidases impairs severe acute respiratory syndrome coronavirus and human coronavirus NL63 spike protein-mediated entry by altering the glycan processing of angiotensin I-converting enzyme 2.

Authors:  Xuesen Zhao; Fang Guo; Mary Ann Comunale; Anand Mehta; Mohit Sehgal; Pooja Jain; Andrea Cuconati; Hanxin Lin; Timothy M Block; Jinhong Chang; Ju-Tao Guo
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

3.  Structure of the main protease from a global infectious human coronavirus, HCoV-HKU1.

Authors:  Qi Zhao; Shuang Li; Fei Xue; Yilong Zou; Cheng Chen; Mark Bartlam; Zihe Rao
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

4.  Cholesterol dependence of varicella-zoster virion entry into target cells.

Authors:  S Hambleton; S P Steinberg; M D Gershon; A A Gershon
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

5.  An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines.

Authors:  Yan Guo; Wenhui He; Huihui Mou; Lizhou Zhang; Jing Chang; Shoujiao Peng; Amrita Ojha; Rubens Tavora; Mark S Parcells; Guangxiang Luo; Wenhui Li; Guocai Zhong; Hyeryun Choe; Michael Farzan; Brian D Quinlan
Journal:  mBio       Date:  2021-05-11       Impact factor: 7.867

6.  SARS coronavirus replicase proteins in pathogenesis.

Authors:  Rachel L Graham; Jennifer S Sparks; Lance D Eckerle; Amy C Sims; Mark R Denison
Journal:  Virus Res       Date:  2007-03-29       Impact factor: 3.303

Review 7.  Host Factors in Coronavirus Replication.

Authors:  Adriaan H de Wilde; Eric J Snijder; Marjolein Kikkert; Martijn J van Hemert
Journal:  Curr Top Microbiol Immunol       Date:  2018       Impact factor: 4.291

8.  Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression.

Authors:  Kerstin Gnirss; Annika Kühl; Christina Karsten; Ilona Glowacka; Stephanie Bertram; Franziska Kaup; Heike Hofmann; Stefan Pöhlmann
Journal:  Virology       Date:  2012-01-04       Impact factor: 3.616

Review 9.  The spike protein of SARS-CoV--a target for vaccine and therapeutic development.

Authors:  Lanying Du; Yuxian He; Yusen Zhou; Shuwen Liu; Bo-Jian Zheng; Shibo Jiang
Journal:  Nat Rev Microbiol       Date:  2009-02-09       Impact factor: 60.633

10.  Ezrin interacts with the SARS coronavirus Spike protein and restrains infection at the entry stage.

Authors:  Jean Kaoru Millet; François Kien; Chung-Yan Cheung; Yu-Lam Siu; Wing-Lim Chan; Huiying Li; Hiu-Lan Leung; Martial Jaume; Roberto Bruzzone; Joseph S Malik Peiris; Ralf Marius Altmeyer; Béatrice Nal
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.